undamentalytics Newsletter
Sign in

Insmed Inc balance sheet

At the end of fiscal 2025, Insmed Inc had total assets of $2.26bn, total liabilities of $1.53bn and shareholders' equity of $739m. It held $510m in cash against $547m of debt: net debt of $36.3m.

Balance sheet

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Fiscal year2009Dec 20092010Dec 20102011Dec 20112012Dec 20122013Dec 20132015Dec 20152016Dec 20162017Dec 20172018Dec 20182019Dec 20192020Dec 20202021Dec 20212022Dec 20222023Dec 20232024Dec 20242025Dec 2025LTMSept 2026
Cash and equivalents—1115911142831633814954875337171,074482555510397
Receivables—010———06191724304152141259
Inventory———————07285067708399132164
Total current assets—10977941162881683895195556238371,2739291,6221,7941,707
Goodwill—60———————0136136136136136136
Total assets—1961401541763572384626057427961,2441,6561,3302,0252,2652,226
Accounts payable—127671015181343365065738084
Deferred revenue (current)—00——————————————
Total current liabilities—3416162228458085119135190226298469597
Short-term debt——0−333—0—————0—010
Long-term debt——016162255563173363565671,1251,1551,103541545
Total debt—0020202555563174504508001,1541,1781,122547555
Total liabilities—36333345831013964815208331,5681,6621,7401,5261,500
Shareholders' equity12419313412114331215436120826227641088−332285739726
Net debt (negative = net cash)—−11−15−71−94−258−108−326−179−37−83838069556736159
Shares outstanding—16m25m31m39m62m62m77m77m90m103m119m136m148m179m214m219m

Balances at each fiscal year end (quarter end in the quarterly view). Total debt is short- plus long-term borrowings, including lease debt where the company reports it within debt. Where assets do not equal liabilities plus shareholders' equity, the difference (non-controlling interests, redeemable preferred shares) is shown on its own line.

Compare with peers

Head to head: HALO vs INSMALKS vs INSMINSM vs MDGL

More: Biotechnology stocks compared, Health Care sector, rankings of US companies

Figures from Insmed Inc's SEC filings (10-K and 10-Q), retrieved October 30, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Insmed Inc.